Myths vs facts: tTG IgA and menopause

The question of myths vs facts regarding tTG IgA and menopause lacks direct evidence in the provided context. tTG IgA (tissue transglutaminase IgA antibodies) is the primary serological marker for celiac disease. A common myth is that elevated tTG IgA during menopause is diagnostic of celiac disease. Fact: false positives can occur in other autoimmune conditions, liver disease, or infections, but a specific link to menopause is not supported by strong evidence. Menopause alters gut microbiota and can exacerbate gastrointestinal symptoms, which may be misinterpreted as celiac disease. Another myth: tTG IgA levels are inherently higher in menopause. No robust data confirm this. The evidence is unclear because most studies do not stratify by menopausal status. Consumers should know that a positive tTG IgA requires confirmatory duodenal biopsy, especially in peri- or postmenopausal women with nonspecific symptoms. Without direct context, the answer remains conservative: tTG IgA is a reliable marker for celiac disease, but menopause does not independently affect its levels. Always consult a physician for interpretation.